Rapid degeneration of cultured human brain pericytes by amyloid β protein

Journal of Neurochemistry

Volumn 68, Issue 3, 1997, Pages 1135-1141

  Verbeek, Marcel M ^a   De Waal, Robert M W ^a   Schipper, Janine J ^b   Van Nostrand, William E ^b,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Amyloid protein; Cerebrovasculature; Degeneration; Pericytes; Smooth muscle cells

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CONGO RED; SYNTHETIC PEPTIDE;

ALZHEIMER DISEASE; ARTICLE; BRAIN CELL; CELL CULTURE; CELL DEATH; CELL DEGENERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; LEPTOMENINX; NEUROPATHOLOGY; PERICYTE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; SMOOTH MUSCLE FIBER;

EID: 0031017399     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68031135.x     Document Type: Article

References (35)

1. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
2. 21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid β/A4-peptide. Neurosci. Lett. 161, 17-20.
3. Davis J. and Van Nostrand W. E. (1996) Enhanced pathologic properties of Dutch-type mutant amyloid β-protein. Proc. Natl. Acad. Sci. USA 93, 2996-3000.
4. Davis-Salinas J. and Van Nostrand W. E. (1995) Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J. Biol. Chem. 270, 20887-20890.
5. Davis-Salinas J., Saporito-Irwin S. M., Cotman C. W., and Van Nostrand W. E. (1995) Amyloid β-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65, 931-934.
6. Diaz-Flores L., Gutierrez R., Varela H., Rancel N., and Valladares F. (1991) Microvascular pericytes: a review of their morphological and functional characteristics. Histol. Histopathol. 6, 269-286.
7. Frackowiak J., Zoltowska A., and Wisniewski H. M. (1994) Non-fibrillar β-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J. Neuropathol. Exp. Neurol. 53, 637-645.
8. Glenner G. G. and Wong C. W. (1984a) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
9. Glenner G. G. and Wong C. W. (1984b) Alzheimer's disease and Down's syndrome sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122, 1131-1135.
10. Glenner G. G., Henry J. H., and Fujihara S. (1981) Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann. Pathol 1, 120-129.
11. Jarrett J. T., Berger E. P., and Lansbury P. T. (1993) The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697.
12. Kang J., Lemaire H., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K., Multhaup G., Beyreuther K., and Müller-Hill B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
13. Kawai M., Kalaria R. N., Cras P., Siedlak S. L., Velasco M. E., Shelton E. R., Chan H. W., Greenberg B., and Perry G. (1993) Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res. 623, 142-146.
14. Khachaturian Z. S. (1985) Diagnosis of Alzheimer's disease. Arch. Neurol. 42, 1097-1104.
15. Levy E., Carman M. D., Fernandez-Madrid I. J., Power M. D., Lieberburg I., van Duinen S. G., Bots G. T. A. M., Luyendijk W., and Frangione B. (1990) Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124-1126.
16. Lorenzo A. and Yankner B. A. (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91, 12243-12247.
17. Luyendijk W., Bots G. T. A. M., Vegter-van der Vlis M., Went L. N., and Frangione B. (1988) Hereditary cerebral haemorrhage caused by cortical amyloid angiopathy. J. Neurol. Sci. 85, 267-280.
18. Mandybur T. I. (1975) The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology 25, 120-126.
19. Morel F. and Wildi F. (1952) General and cellular pathochemistry of senile and presenile alterations of the brain, in Proceedings of the 1st International Congress on Neuropathology, Rome, pp. 347-374. Rosenberg and Sellier, Torino, Italy.
20. Pike C. J., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1991) In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311-314.
21. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
22. Ponte P., Gonzalez-DeWhitt P., Schilling J., Miller J., Hsu D., Greenberg B., Davis K., Wallace W., Lieberburg I., Fuller F., and Cordell B. (1988) A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 331, 525-532.
23. Rhodin J. A. G. (1980) Architecture of the vessel wall, in Handbook of Physiology, Section 2: The Cardiovascular System (Bohr D. F., Somlyo A. P., Sparks H. V., and Geiger S. R., eds), pp. 1-31. American Physiological Society, Bethesda, Maryland.
24. Scholz W. (1938) Studien zur Pathologie der Hirngefasse: Die drusige Entartung der Hirnarterien und Kapillaren (Eine form senilar Gefasserkrankung ). Z. Gesamte Neurol. Psychiatrie 162, 694-715.
25. Shoji M., Hirai S., Harigaya Y., Kawarabayashi T., and Yamaguchi H. (1990) The amyloid β-protein precursor is localized in smooth muscle cells of leptomeningeal vessels. Brain Res. 530, 113-116.
26. Tagliavini F., Ghiso J., Timmers W. F., Giaccone G., Bugiani O., and Frangione B. (1990) Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. Lab. Invest. 62, 761-767.
27. Van Nostrand W. E., Wagner S. L., Suzuki M., Choi B. H., Farrow J. S., Geddes J. W., Cotman C. W., and Cunningham D. D. (1989) Protease nexin-II, a potent anti-chymotrypsin, shows identity to amyloid β-protein precursor. Nature 341, 546-549.
28. Van Nostrand W. E., Rozenmuller J. M., Chung R., Cotman C. W., and Saporito-Irwin S. M. (1994) Amyloid β-protein precursor in cultured leptomeningeal smooth muscle cells. Amyloid Int. J. Exp. Clin. Invest. 1, 1-7.
29. Verbeek M. M., Otte-Höller I., Wesseling P., Ruiter D. J., and de Waal R. M. W. (1994) Induction of α-smooth muscle actin expression in cultured human brain pericytes by TGFβ1. Am. J. Pathol. 144, 372-382.
30. Verbeek M. M., Westphal J. R., Ruiter D. J., and de Waal R. M. W. (1995) T lymphocyte adhesion to human brain pericytes is mediated via VLA-4/VCAM-1 interactions. J. Immunol. 154, 5876-5884.
31. Wisniewski H. M. and Wegiel J. (1994) β-Amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol. (Berl.) 87, 233-241.
32. Wisniewski T., Ghiso J., and Frangione B. (1991) Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem. Biophys. Res. Commun. 179, 1247-1254.
33. Wisniewski H. M., Wegiel J., Wang K. C., and Lach B. (1992) Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol. (Berl.) 84, 117-127.
34. Yamaguchi H., Yamazaki T., Lemere C. A., Frosch M. P., and Selkoe D. J. (1992) Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. Am. J. Pathol. 141, 249-259.
35. Yankner B. A., Duffy L. K., and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250, 279-282.